StockData
Colgate Palmolive Co logo

Colgate Palmolive Co (CL) stock

CLNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3030% above fair value
$99.61−1.38 (-1.37%)

Close on Nov 17, 2026Market cap $79.18BP/E 39.1Yield 2.09%

Colgate Palmolive operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Colgate Palmolive's operating income for the twelve months ending Sep 30, 2026 was $3.16B, down 26.1% year over year. For fiscal 2025 it was $3.31B, down 22.5% from the year before. Over ten years it grew 1.7% a year on average. The highest annual figure on record is $4.27B in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.31B-22.5%
FY2024Dec 31, 2024$4.27B+7.1%
FY2023Dec 31, 2023$3.98B+37.7%
FY2022Dec 31, 2022$2.89B-13.2%
FY2021Dec 31, 2021$3.33B-14.2%
FY2020Dec 31, 2020$3.89B+9.3%
FY2019Dec 31, 2019$3.55B-3.8%
FY2018Dec 31, 2018$3.69B-0.4%
FY2017Dec 31, 2017$3.71B-6.3%
FY2016Dec 31, 2016$3.96B+41.8%
FY2015Dec 31, 2015$2.79B-21.6%
FY2014Dec 31, 2014$3.56B+0.0%
FY2013Dec 31, 2013$3.56B-8.6%
FY2012Dec 31, 2012$3.89B+1.2%
FY2011Dec 31, 2011$3.84B+10.1%
FY2010Dec 31, 2010$3.49B-3.5%
FY2009Dec 31, 2009$3.62B+16.6%
FY2008Dec 31, 2008$3.10B+14.0%
FY2007Dec 31, 2007$2.72B–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.09B+2.7%
Q2 FY2026Jun 30, 2026$1.02B-5.9%
Q1 FY2026Mar 31, 2026$964.00M-10.4%
Q4 FY2025Dec 31, 2025$92.00M-91.3%
Q3 FY2025Sep 30, 2025$1.06B-0.6%
Q2 FY2025Jun 30, 2025$1.08B-1.1%
Q1 FY2025Mar 31, 2025$1.08B+2.8%
Q4 FY2024Dec 31, 2024$1.06B-0.8%
Q3 FY2024Sep 30, 2024$1.07B+3.5%
Q2 FY2024Jun 30, 2024$1.09B+12.1%
Q1 FY2024Mar 31, 2024$1.05B+15.2%
Q4 FY2023Dec 31, 2023$1.07B+430.7%
Q3 FY2023Sep 30, 2023$1.03B+8.7%
Q2 FY2023Jun 30, 2023$974.00M+10.2%
Q1 FY2023Mar 31, 2023$909.00M+5.7%
Q4 FY2022Dec 31, 2022$202.00M-44.7%
Q3 FY2022Sep 30, 2022$947.00M-2.1%
Q2 FY2022Jun 30, 2022$884.00M-11.2%
Q1 FY2022Mar 31, 2022$860.00M-14.3%
Q4 FY2021Dec 31, 2021$365.00M-62.3%
Q3 FY2021Sep 30, 2021$967.00M-5.0%
Q2 FY2021Jun 30, 2021$996.00M+5.3%
Q1 FY2021Mar 31, 2021$1.00B+5.5%
Q4 FY2020Dec 31, 2020$969.00M+4.1%
Q3 FY2020Sep 30, 2020$1.02B+18.9%
Q2 FY2020Jun 30, 2020$946.00M+6.5%
Q1 FY2020Mar 31, 2020$952.00M+8.3%
Q4 FY2019Dec 31, 2019$931.00M+4.5%
Q3 FY2019Sep 30, 2019$856.00M-2.1%
Q2 FY2019Jun 30, 2019$888.00M-6.1%
Q1 FY2019Mar 31, 2019$879.00M-10.6%
Q4 FY2018Dec 31, 2018$891.00M-7.2%
Q3 FY2018Sep 30, 2018$874.00M-8.7%
Q2 FY2018Jun 30, 2018$946.00M+7.7%
Q1 FY2018Mar 31, 2018$983.00M+7.8%
Q4 FY2017Dec 31, 2017$960.00M-10.5%
Q3 FY2017Sep 30, 2017$957.00M–
Q2 FY2017Jun 30, 2017$878.00M–
Q1 FY2017Mar 31, 2017$912.00M–
Q4 FY2016Dec 31, 2016$1.07B–

More Colgate Palmolive figures

See a number that looks wrong?